+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Deaths in custody: are some due to electronic control devices (including TASER devices) or excited delirium?



Deaths in custody: are some due to electronic control devices (including TASER devices) or excited delirium?



Journal of Forensic and Legal Medicine 17(1): 1-7



Deaths have occurred after law-enforcement incidents involving applications of electronic control devices (ECDs) (including TASER devices). An "excited delirium" syndrome (reported in the literature prior to the development of ECDs currently in use), however, includes several factors that may be related to such deaths in custody. In this review, potential detrimental effects of ECDs are compared with possible changes due to excited delirium. Although extreme (i.e., long-duration or repeated) exposures to ECDs can result in significant hyperkalaemia, acidaemia, and myoglobinemia in animal models, limited applications (such as those normally used in law-enforcement situations) would appear to have only transient effects. In addition, the hyperthermia observed in patients with excited delirium does not seem to be directly exacerbated by ECD applications. ECD use is unlikely to be a common cause of ventricular fibrillation, but other events that are generally associated with excited delirium (e.g., drug use) may be related to subsequent ventricular fibrillation or asystole. Metabolic or respiratory acidosis may only be serious consequences of long-duration or repeated ECD applications. On the basis of current available information, factors other than ECDs themselves may be more important when death occurs after the use of ECDs.

(PDF emailed within 0-6 h: $19.90)

Accession: 052454450

Download citation: RISBibTeXText

PMID: 20083043

DOI: 10.1016/j.jflm.2008.05.011


Related references

Pathophysiologic changes due to TASER® devices versus excited delirium: potential relevance to deaths-in-custody?. Journal of Forensic and Legal Medicine 18(4): 145-153, 2011

TASER electronic control devices and eye injuries. Documenta Ophthalmologica. Advances in Ophthalmology 124(2): 157-159, 2012

Health effects of TASER™ electronic control devices. Journal of Emergency Nursing: Jen 40(5): 415-415, 2015

Sensitive swine and TASER electronic control devices. Academic Emergency Medicine 15(7): 695-6; Author Reply 696-8, 2009

Physiology and pathology of TASER electronic control devices. Journal of Forensic and Legal Medicine 16(4): 173-177, 2009

Sensitive Swine and TASER Electronic Control Devices. Academic Emergency Medicine 15(7): 695-696, 2008

TASER electronic control devices can cause cardiac arrest in humans. Circulation 129(1): 101-111, 2014

TASER electronic control devices and cardiac arrests: coincidental or causal?. Circulation 129(1): 93-100, 2014

Excited delirium deaths in custody: past and present. American Journal of Forensic Medicine and Pathology 30(1): 1-5, 2009

Factors associated with excited delirium deaths in police custody. Modern Pathology 11(11): 1127-1137, 1998

Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community. Cmaj 158(12): 1603-1607, 1998

Exposures to conducted electrical weapons (including TASER® devices): how many and for how long are acceptable?. Journal of Forensic Sciences 60 Suppl 1: S116-S129, 2016

Increased hematocrit after applications of conducted energy weapons (including TASER(®) devices) to Sus scrofa. Journal of Forensic Sciences 56 Suppl 1: S229-S233, 2011

An animal model to investigate effectiveness and safety of conducted energy weapons (including TASER devices). Journal of Forensic Sciences 55(2): 521-526, 2010

Tactical and subject considerations of in-custody deaths proximal to use of conductive energy devices. American Journal of Forensic Medicine and Pathology 30(1): 23-25, 2009